Chen D. Gou to Become Chairman of Braincure-Biotech.com
Braincure Biotech (ISIN:TW0001327872) has recently appointed Chen D. Gou will become Chairman of the Company's Board of Directors, effective immediately. The appointment follows the decision by Tsao T. Wenjung, 65, the Company's former Chairman, to retire from his position. Mr. Wenjung will retire from the Board at the Company's Annual Shareholder Meeting.
Braincure-Biotech.com Names Lee Yung Lung Chief Operating Officer
Braincure Biotech (ISIN:TW0001327872) has recently appointed Mr. Lee Yung Lung as the Chief Operating Officer (COO) of the company.
Researchers Report Artemin Virtually Restores Complete Long-Term Sensory Motor Function in Preclinical Studies
Braincure-Biotech.com (ISIN:TW0001327872) reported that in preclinical studies, injections of the protein Artemin promoted the regeneration of damaged sensory nerve cells and produced virtually complete, long-term restoration of sensory and motor function.